Back to Search Start Over

Findings from University of Ulsan in ovarian cancer reported

Source :
Cancer Weekly. July 13, 2010, p23.
Publication Year :
2010

Abstract

New investigation results, 'The efficacy and toxicity of belotecan (CKD-602), a camptothericin analogue topoisomerase I inhibitor, in patients with recurrent or refractory epithelial ovarian cancer,' are detailed in a study [...]

Subjects

Subjects :
Camptothecin -- Reports
Cancer -- Care and treatment
Universities and colleges -- Reports
Ovarian cancer -- Care and treatment -- Reports

Details

Language :
English
ISSN :
15324567
Database :
Gale General OneFile
Journal :
Cancer Weekly
Publication Type :
News
Accession number :
edsgcl.231226438

Tools

Authors Abstract Subjects Details